Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

Share Price is delayed by 15 minutes
Get Live Data
62.75    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.50 (4.065%)
Market Cap: £5.76m
CPP Live PriceLast checked at - London Stock Exchange

Intraday Cppgroup Share Chart

Company Update

10 Apr 2026 12:34

RNS Number : 0371A
CPPGroup PLC
10 April 2026
 

CPPGroup Plc

("CPP"; "the Group"; or "the Company")

 

COMPANY UPDATE

 

The Board of CPP Group provides the following update on the strategic options currently being actively progressed, subsequent to the Company's announcement on 16th March.

 

Strategic review and potential sale of Blink

The Board is exploring strategic options for Blink Parametric Holdings Limited ("Blink"), the Group's digitally focused parametric InsurTech business, which has received significant investment in recent years and continues to perform strongly and in line with Board expectations.

 

Blink is a technology-led platform providing real-time, automated claims assessment and payment solutions, primarily within the travel disruption insurance and cyber protection markets. It has established a growing network of global partnerships with insurers, financial institutions and travel providers, with an expanding presence across multiple geographies.

 

For the year ended 31 December 2025, Blink is expected to report annualised recurring revenue ("ARR") of circa £3 million (2024: £1.6 million), representing strong year-on-year growth. This momentum has continued with a strong Q1 2026, and we expect, by year end, to report another year of strong revenue growth.

 

The Board is encouraged by the level of external interest in Blink and has received proposals and expressions of interest, including from strategic industry participants, in relation to a potential acquisition or combination involving the business. The proposals reflect valuation levels which are significantly in excess of the Group's current market capitalisation, reinforcing confidence in Blink's underlying value and future growth potential.

 

The Board is therefore pursuing a potential sale of Blink. No terms have been agreed at this stage, and there can be no certainty that any transaction will be completed or as to the value that may ultimately be realised.

 

Liquidity and Financing

Whilst the Group does not expect to receive any deferred consideration in relation to the disposal of CPP India, the validity of the reasons presented by the purchaser of CPP India continue to be questioned. Based on the Group's current resources of approximately £4 million, together with the Board's assessment of the regulatory capital requirements of its legacy regulated businesses, and in the absence of new capital, the Company currently expects to have sufficient resources to fund its working capital requirements through to the end of the third quarter of 2026.

 

In light of this, the Board is also progressing discussions with a range of parties, including existing shareholders and potential new investors, regarding funding options to support the Group. These discussions are focused on enhancing financial flexibility in order to:

 

1. fund the Group's ongoing operating requirements;

2. support the continued development and growth of Blink;

3. provide capital for the regulated businesses in run-off; and

4. extend the Group's available cash runway.

 

A range of funding structures is under consideration, and a further announcement will be made in due course.

 

The Board remains focused on delivering an outcome that maximises shareholder value while ensuring the Group maintains an appropriate and sustainable funding position.

 

 

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of CPP Group is Sarah Atherton, General Counsel and Company Secretary.

 

 

 

 

ENQUIRIES

 

CPPGroup plc

David Morrison, Chairman via H2 Radnor Email: info@h2radnor.com

Simon Pyper, Chief Financial Officer Tel: +44 (0)203 897 1830

 

Panmure Liberum

(Nominated Adviser and Sole Broker) Tel: +44 (0)20 310 2000

Stephen Jones

Atholl Tweedie

Will King

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBBGDSDXBDGLG
Date   Source Headline
2nd Nov 20174:15 pmRNSDirector/PDMR Shareholding
2nd Nov 20179:45 amRNSHolding(s) in Company
2nd Nov 20179:17 amRNSDirector/PDMR Shareholding
30th Oct 20174:45 pmRNSChange of Registered Office
27th Oct 201711:45 amRNSDirector/PDMR Shareholding
25th Oct 201712:20 pmRNSDirector/PDMR Shareholding
24th Aug 20177:00 amRNSHalf-year Report
11th Aug 20172:14 pmRNSBlock listing Interim Review
1st Aug 201712:50 pmRNSDirectorate Change
27th Jun 201710:15 amRNSStatement re Card Protection Plan Limited
21st Jun 201710:00 amRNSBlock listing Interim Review
20th Jun 20172:18 pmRNSAdditional Listing
19th May 20173:01 pmRNSResult of AGM
16th May 201710:30 amRNSStatement re Homecare Insurance Limited
21st Apr 20172:28 pmRNSDirector/PDMR Shareholding
19th Apr 20177:00 amRNSDirectorate Change
18th Apr 201710:08 amRNSDirector/PDMR Shareholding
13th Apr 20179:00 amRNSNotice of AGM
12th Apr 20174:43 pmRNSDirector/PDMR Shareholding
29th Mar 20175:57 pmRNSHolding(s) in Company
29th Mar 20175:27 pmRNSDirector/PDMR Shareholding
24th Mar 20177:00 amRNSDirectorate Change
24th Mar 20177:00 amRNSAnnual Financial Report
17th Mar 20177:00 amRNSAcquisition
13th Feb 201712:08 pmRNSBlock listing Interim Review
30th Jan 20174:41 pmRNSSecond Price Monitoring Extn
30th Jan 20174:37 pmRNSPrice Monitoring Extension
17th Jan 201712:05 pmRNSPrice Monitoring Extension
30th Dec 20163:33 pmRNSStatement re IT Platform
23rd Dec 20162:23 pmRNSHolding(s) in Company
16th Dec 20169:41 amRNSBlock listing Interim Review
8th Dec 20164:41 pmRNSSecond Price Monitoring Extn
8th Dec 20164:37 pmRNSPrice Monitoring Extension
7th Dec 20164:36 pmRNSPrice Monitoring Extension
18th Nov 20167:00 amRNSTrading Statement
14th Sep 20165:16 pmRNSStatement re IT Platform
18th Aug 20167:00 amRNSHalf-year Report
15th Aug 201611:40 amRNSBlock listing Interim Review
26th Jul 20166:19 pmRNSDirectorate Change
6th Jul 20164:00 pmRNSHolding(s) in Company
5th Jul 20169:15 amRNSTotal Voting Rights
21st Jun 201612:44 pmRNSAdditional Listing
17th Jun 20169:53 amRNSBlock listing Interim Review
19th May 20167:00 amRNSDirectorate Change
18th May 20164:50 pmRNSResult of AGM
18th May 20167:00 amRNSChange of Adviser
16th May 20165:23 pmRNSAGM Statement
16th May 20167:00 amRNSDirectorate Change
9th May 20163:19 pmRNSAGM Statement
6th May 20164:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.